Herbalife Ltd

HLF is consolidating near recent lows under declining long-term moving averages, indicating that supply remains dominant and upside conviction is lacking. With price below the 50- and 200-day averages and no active reversal patterns, the medium-term bias is bearish. Execution should be deferred: focus on selling into rallies toward the EMA/50 DMA cluster and the 200-day SMA, watching for rejection and normalized volume to confirm supply. A sustained breakout above these averages on strength would invalidate the bearish thesis and require reevaluation.

• ↑Net sales +5.4% YoY to $1.3B in Q2, fourth consecutive growth
• ↑FCF yield >23% with $147M operating cash flow in H1 2026
• ↓Net loss $26M in Q2 due to debt extinguishment, underscoring profitability strain